1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow HER2-addicted Breast Cancer: new trials by email Literature Review of HER2-addicted Breast Cancer trials Research Report on HER2-addicted Breast Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Retifanlimab With Trastuzumab and Pertuzumab Combination in HER2-Addicted Breast Cancer Retifanlimab, Trastuzumab (Herceptin), Pertuzumab - HER2-addicted Breast Cancer | Phase 2 | Not yet recruiting | Polly A. Niravath, MD | 30 | 2026-12-31 | 2026-08-19 |
Trastuzumab (1) · pertuzumab (1)